Literature DB >> 30215546

Pre-clinical imaging for establishment and comparison of orthotopic non-small cell lung carcinoma: in search for models reflecting clinical scenarios.

Rozina Aktar1,2,3, Antje Dietrich1,2,3, Falk Tillner1,4,5, Shady Kotb1,2,3, Steffen Löck1,2,3,4, Henning Willers6, Michael Baumann1,2,3,4,5, Mechthild Krause1,2,3,4,5,7, Rebecca Bütof1,3,4,7.   

Abstract

OBJECTIVE: : Clinically relevant animal models of non-small cell lung carcinoma (NSCLC) are required for the validation of novel treatments. We compared two different orthotopic transplantation techniques as well as imaging modalities to identify suitable mouse models mimicking clinical scenarios.
METHODS: : We used three genomically diverse NSCLC cell lines [National Cancer Institute (NCI)-H1703 adenosquamous cell carcinoma, NCI-H23 adenocarcinoma and A549 adenocarcinoma) for implanting tumour cells either as spheroids or cell suspension into lung parenchyma. Bioluminescence imaging (BLI) and contrast-enhanced cone beam CT (CBCT) were performed twice weekly to monitor tumour growth. Tumour histological data and microenvironmental parameters were determined.
RESULTS: : Tumour development after spheroid-based transplantation differs probably due to the integrity of spheroids, as H1703 developed single localised nodules, whereas H23 showed diffuse metastatic spread starting early after transplantation. A549 transplantation as cell suspension with the help of a stereotactic system was associated with initial single localised tumour growth and eventual metastatic spread. Imaging techniques were successfully applied to monitor longitudinal tumour growth: BLI revealed highly sensitive qualitative data, whereas CBCT was associated with less sensitive quantitative data. Histology revealed significant model-dependent heterogeneity in proliferation, hypoxia, perfusion and necrosis.
CONCLUSION: : Our developed orthotopic NSCLC tumours have similarity with biological growth behaviour comparable to that seen in the clinic and could therefore be used as attractive models to study tumour biology and evaluate new therapeutic strategies. The use of human cancer cell lines facilitates testing of different genomic tumour profiles that may affect treatment outcomes. ADVANCES IN KNOWLEDGE:: The combination of different imaging modalities to identify tumour growth with subsequent use in treatment planning and orthotopic transplantation techniques to develop initially single lesions to ultimate metastases pave the way towards representative pre-clinical NSCLC models for experimental testing of novel therapeutic options in future studies.

Entities:  

Mesh:

Year:  2018        PMID: 30215546      PMCID: PMC6541193          DOI: 10.1259/bjr.20180539

Source DB:  PubMed          Journal:  Br J Radiol        ISSN: 0007-1285            Impact factor:   3.039


  34 in total

1.  Histology and sensitivity to anticancer drugs of two human non-small cell lung carcinomas implanted in the pleural cavity of nude mice.

Authors:  L Kraus-Berthier; M Jan; N Guilbaud; M Naze; A Pierré; G Atassi
Journal:  Clin Cancer Res       Date:  2000-01       Impact factor: 12.531

2.  An improved orthotopic xenotransplant procedure for human lung cancer in SCID bg mice.

Authors:  A S Boehle; P Dohrmann; I Leuschner; H Kalthoff; D Henne-Bruns
Journal:  Ann Thorac Surg       Date:  2000-04       Impact factor: 4.330

3.  Prognostic significance of p27KIP1 protein and ki-67 growth fraction in non-small cell lung cancers.

Authors:  F Hommura; H Dosaka-Akita; T Mishina; M Nishi; T Kojima; H Hiroumi; S Ogura; M Shimizu; H Katoh; Y Kawakami
Journal:  Clin Cancer Res       Date:  2000-10       Impact factor: 12.531

Review 4.  Advancing animal models of neoplasia through in vivo bioluminescence imaging.

Authors:  M Edinger; Y-a Cao; Y S Hornig; D E Jenkins; M R Verneris; M H Bachmann; R S Negrin; C H Contag
Journal:  Eur J Cancer       Date:  2002-11       Impact factor: 9.162

5.  Pimonidazole labelling and response to fractionated irradiation of five human squamous cell carcinoma (hSCC) lines in nude mice: the need for a multivariate approach in biomarker studies.

Authors:  Ala Yaromina; Daniel Zips; Howard D Thames; Wolfgang Eicheler; Mechthild Krause; Andrea Rosner; Michael Haase; Cordula Petersen; James A Raleigh; Verena Quennet; Stefan Walenta; Wolfgang Mueller-Klieser; Michael Baumann
Journal:  Radiother Oncol       Date:  2006-09-07       Impact factor: 6.280

Review 6.  Orthotopic metastatic mouse models for anticancer drug discovery and evaluation: a bridge to the clinic.

Authors:  R M Hoffman
Journal:  Invest New Drugs       Date:  1999       Impact factor: 3.850

7.  Development of an orthotopic model to study the biology and therapy of primary human lung cancer in nude mice.

Authors:  Amir Onn; Takeshi Isobe; Satoshi Itasaka; Wenjuan Wu; Michael S O'Reilly; Waun Ki Hong; Isaiah J Fidler; Roy S Herbst
Journal:  Clin Cancer Res       Date:  2003-11-15       Impact factor: 12.531

Review 8.  Orthotopic models of cancer for preclinical drug evaluation: advantages and disadvantages.

Authors:  M C Bibby
Journal:  Eur J Cancer       Date:  2004-04       Impact factor: 9.162

9.  Induction of small cell lung cancer by somatic inactivation of both Trp53 and Rb1 in a conditional mouse model.

Authors:  Ralph Meuwissen; Sabine C Linn; R Ilona Linnoila; John Zevenhoven; Wolter J Mooi; Anton Berns
Journal:  Cancer Cell       Date:  2003-09       Impact factor: 31.743

View more
  5 in total

Review 1.  Preclinical models of radiation-induced lung damage: challenges and opportunities for small animal radiotherapy.

Authors:  Mihaela Ghita; Victoria Dunne; Gerard G Hanna; Kevin M Prise; Jaqueline P Williams; Karl T Butterworth
Journal:  Br J Radiol       Date:  2019-02-13       Impact factor: 3.039

2.  Cancer cell-intrinsic expression of MHC II in lung cancer cell lines is actively restricted by MEK/ERK signaling and epigenetic mechanisms.

Authors:  Alexander J Neuwelt; Abigail K Kimball; Amber M Johnson; Benjamin W Arnold; Bonnie L Bullock; Rachael E Kaspar; Emily K Kleczko; Jeff W Kwak; Meng-Han Wu; Lynn E Heasley; Robert C Doebele; Howard Y Li; Raphael A Nemenoff; Eric T Clambey
Journal:  J Immunother Cancer       Date:  2020-04       Impact factor: 13.751

3.  Establishment and evaluation of ectopic and orthotopic prostate cancer models using cell sheet technology.

Authors:  Dongliang Zhang; Ying Wang; Lei Liu; Zeng Li; Shengke Yang; Weixin Zhao; Xiang Wang; Hong Liao; Shukui Zhou
Journal:  J Transl Med       Date:  2022-08-29       Impact factor: 8.440

4.  Screening and Validation of Molecular Targeted Radiosensitizers.

Authors:  Henning Willers; Xiao Pan; Nathalie Borgeaud; Irina Korovina; Lydia Koi; Regina Egan; Patricia Greninger; Aliza Rosenkranz; Jong Kung; Andrew S Liss; Leslie A Parsels; Meredith A Morgan; Theodore S Lawrence; Steven H Lin; Theodore S Hong; Beow Y Yeap; Lori J Wirth; Aaron N Hata; Christopher J Ott; Cyril H Benes; Michael Baumann; Mechthild Krause
Journal:  Int J Radiat Oncol Biol Phys       Date:  2021-07-31       Impact factor: 7.038

5.  Biocompatibility and Degradation Behavior of Molybdenum in an In Vivo Rat Model.

Authors:  Antje Schauer; Christian Redlich; Jakob Scheibler; Georg Poehle; Peggy Barthel; Anita Maennel; Volker Adams; Thomas Weissgaerber; Axel Linke; Peter Quadbeck
Journal:  Materials (Basel)       Date:  2021-12-16       Impact factor: 3.623

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.